Junxin Wu Selected Research

Junxin Wu Research Topics

Disease

17	Neoplasms (Cancer) 12/2023 - 07/2010
15	Rectal Neoplasms (Rectal Cancer) 03/2024 - 01/2017
6	Neoplasm Metastasis (Metastasis) 04/2022 - 03/2015
5	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 11/2019
4	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 01/2022
4	Nasopharyngeal Carcinoma 01/2016 - 07/2010
3	Stroke (Strokes) 01/2023 - 01/2022
3	Inflammation (Inflammations) 01/2023 - 01/2019
2	Bites and Stings (Sting) 12/2023 - 11/2023
2	Hypoxia (Hypoxemia) 12/2023 - 11/2023
2	Cognitive Dysfunction 01/2023 - 01/2023
2	Sigmoid Neoplasms 05/2022 - 01/2021
2	Breast Neoplasms (Breast Cancer) 08/2021 - 11/2019
1	Colonic Neoplasms (Colon Cancer) 10/2022
1	Carcinogenesis 01/2022
1	Extranodal Extension 01/2022
1	Fatigue 01/2022
1	Hyperglycemia 01/2022
1	Rare Diseases (Rare Disease) 08/2021
1	Glioma (Gliomas) 01/2021
1	Adenocarcinoma 12/2020
1	Pathologic Complete Response 12/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2020
1	Neutropenia 03/2020
1	Dermatofibrosarcoma 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2013
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 08/2012
1	Lung Injury 08/2012
1	Anemia 07/2010
1	Ataxia Telangiectasia (Louis Bar Syndrome) 05/2006

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2024 - 06/2020
3	Proteins (Proteins, Gene)FDA Link 06/2020 - 01/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 11/2023
2	Interferon Type IIBA 12/2023 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 04/2022
2	Phosphotransferases (Kinase)IBA 01/2021 - 05/2006
2	Amifostine (Ethyol)FDA LinkGeneric 01/2016 - 08/2012
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 12/2023
1	Programmed Cell Death 1 ReceptorIBA 11/2023
1	Radiation-Sensitizing AgentsIBA 11/2023
1	Pyruvaldehyde (Methylglyoxal)IBA 11/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	IronIBA 01/2023
1	AlbuminsIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	6-methyladenineIBA 01/2023
1	Long Noncoding RNAIBA 10/2022
1	Tissue Inhibitor of Metalloproteinase-1IBA 04/2022
1	tyramine-deoxysorbitolIBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Uric Acid (Urate)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Transient Receptor Potential ChannelsIBA 01/2022
1	4-azidobenzylcarazolol (pABC)IBA 08/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 02/2021
1	phthalocyanineIBA 02/2021
1	ChloridesIBA 02/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2021
1	Photosensitizing Agents (Photosensitizers)IBA 02/2021
1	AcidsIBA 02/2021
1	Carcinoembryonic AntigenIBA 01/2021
1	Capecitabine (Xeloda)FDA Link 12/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2020
1	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 12/2020
1	Uridine Diphosphate (UDP)IBA 12/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2020
1	Protein Subunit VaccinesIBA 01/2020
1	AntigensIBA 01/2020
1	Peptides (Polypeptides)IBA 11/2019
1	VaccinesIBA 11/2019
1	Oncogene Proteins (Oncogene Protein)IBA 11/2019
1	TetraspaninsIBA 11/2019
1	Radiation-Protective Agents (Radiation Protectants)IBA 01/2016
1	AntioxidantsIBA 08/2012
1	Recombinant ProteinsIBA 08/2012

Therapy/Procedure

13	Radiotherapy 03/2024 - 08/2012
10	Neoadjuvant Therapy 03/2024 - 07/2010
5	Drug Therapy (Chemotherapy) 11/2023 - 03/2015
4	Immunotherapy 01/2024 - 10/2022
3	Therapeutics 11/2023 - 01/2016
2	Radioimmunotherapy 12/2023 - 11/2023
2	Adjuvant Radiotherapy 05/2022 - 01/2021
2	Chemoradiotherapy 01/2022 - 12/2020
1	Hepatectomy 10/2022
1	Photochemotherapy (Photodynamic Therapy) 02/2021
1	Radiofrequency Ablation 01/2020
1	Brachytherapy 09/2013